Shan Fu
Chairman chez TOT BIOPHARM INTERNATIONAL COMPANY LIMITED
Profil
Shan Fu joined Vivo in 2013 as a Managing Partner, Co-CEO and CEO of Greater China.
Before joining Vivo, Mr. Fu worked for Blackstone as Senior Managing Director in the Private Equity group and the Chief Representative of Blackstone’s Beijing Office.
Mr. Fu also worked in the Department of Foreign Investment in China’s National Development and Reform Commission (NDRC), the State Economic and Trade Commission of China, the Office of Economic and Trade in State Council of China, and the Office of Production in State Council of China.
Mr. Fu received a Bachelor’s and Master’s Degree in History from Peking University in Beijing, China.
Postes actifs de Shan Fu
Sociétés | Poste | Début |
---|---|---|
SINOVAC BIOTECH LTD. | Director/Board Member | 01/07/2018 |
TOT BIOPHARM INTERNATIONAL COMPANY LIMITED | Chairman | 28/09/2018 |
NEW FRONTIER HEALTH CORPORATION | Director/Board Member | 09/12/2019 |
LEPU SCIENTECH MEDICAL TECHNOLOGY (SHANGHAI) CO., LTD. | Director/Board Member | 09/06/2021 |
GENETRON HOLDINGS LIMITED | Director/Board Member | 01/06/2021 |
VISEN Pharmaceuticals (Shanghai) Co., Ltd.
VISEN Pharmaceuticals (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology VISEN Pharmaceuticals (Shanghai) Co., Ltd. is a Chinese pharmaceutical company that focuses on the development of products and technology for endocrine diseases. The company is based in Shanghai, China, and the CEO of the company is An Bang Lu. The company has developed a product called Long Pei, which is the first American FDA-approved growth hormone that can be released within a week to deliver growth hormone. VISEN Pharmaceuticals has also entered into a strategic cooperation agreement with Peking University Clinical Research Institute to carry out clinical research on thyroid dysfunction. | Director/Board Member | 01/11/2018 |
VISEN Pharmaceuticals
VISEN Pharmaceuticals BiotechnologyHealth Technology VISEN Pharmaceuticals operates as a biopharmaceutical company. It focuses on developing therapies and patient-centric care on endocrine diseases. The firm operates a segment which is developing and commercializing paradigm-shifting endocrine therapies in Greater China. The company was founded on November 1, 2018 and is headquartered in Shanghai, China. | Director/Board Member | 01/11/2018 |
Esco Lifesciences Group Ltd.
Esco Lifesciences Group Ltd. Miscellaneous Commercial ServicesCommercial Services Esco Lifesciences Group Ltd. is a multinational life sciences company, engages in the development, manufacture, and sale of life sciences, pharmaceutical and bioprocessing tools as well as the offering of related after-sales and support services. It operates through the following segments: Esco Scientific, Esco Medical, Esco Healthcare, and Esco Services. The Esco Scientific segment provides mission critical life sciences laboratory equipment such as biological safety cabinets, laminar flow clean benches, CO2 and CO2/O2 incubators, fume hoods, centrifuges and others used in research, clinical and industrial settings for preparation, cultivation, handling and analytical purposes. The Esco Medical segment manufactures and sells medical devices such as incubators, workstations, and consumables for IVF treatment. The Esco Healthcare segment provides pharmaceutical equipment and bioprocessing tools, primarily containment and isolation systems for the production of medicines, vaccines, and cell and gene therapies. The Esco Services segment offers after-sales and support services to customers of Esco Scientific, Esco Medical, and Esco Healthcare. The company was founded on February 1, 2021 and is headquartered in Singapore. | Director/Board Member | 25/05/2021 |
dMed Biopharmaceutical Technology (Shanghai) Co., Ltd.
dMed Biopharmaceutical Technology (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology DMed Biopharmaceutical Technology Shanghai Co., Ltd. engages in the development of medicines and medical devices. The company was founded by Ling Shi Tan on August 3, 2016 and is headquartered in Shanghai, China. | Director/Board Member | 19/11/2019 |
░░░░ ░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Shan Fu
Sociétés | Poste | Fin |
---|---|---|
░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░ ░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░ ░░░░ ░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░░░░ ░░░░░ ░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░ ░░░░░ ░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Shan Fu
Peking University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 4 |
---|---|
SINOVAC BIOTECH LTD. | Health Technology |
TOT BIOPHARM INTERNATIONAL COMPANY LIMITED | Health Technology |
INNOCARE PHARMA LIMITED | Health Technology |
LEPU SCIENTECH MEDICAL TECHNOLOGY (SHANGHAI) CO., LTD. | Commercial Services |
Entreprise privées | 12 |
---|---|
Vivo Capital LLC
Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California. | Finance |
China Animal Healthcare Ltd.
China Animal Healthcare Ltd. Pharmaceuticals: MajorHealth Technology China Animal Healthcare Ltd. engages in the manufacture, sale and distribution of compound chemical drugs and biological drugs for poultry and livestock. The company was founded by Yan Gang Wang in 1996 and is headquartered in Beijing, China. | Health Technology |
National Development & Reform Commission | Government |
State Economic & Trade Commission | |
The Blackstone Group
The Blackstone Group Investment ManagersFinance Part of Blackstone, Inc., The Blackstone Group enables leading energy companies to build enterprises at scale that can deliver clean, reliable and affordable energy to help meet needs. The private company is based in Beijing, China. The Chinese company invests in companies shaping the future, helping emerging leaders become champions through the power of the Blackstone platform. | Finance |
dMed Biopharmaceutical Technology (Shanghai) Co., Ltd.
dMed Biopharmaceutical Technology (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology DMed Biopharmaceutical Technology Shanghai Co., Ltd. engages in the development of medicines and medical devices. The company was founded by Ling Shi Tan on August 3, 2016 and is headquartered in Shanghai, China. | Health Technology |
Blackstone (Shanghai) Equity Invt Mgmt Co. Ltd.
Blackstone (Shanghai) Equity Invt Mgmt Co. Ltd. Investment ManagersFinance Part of Blackstone, Inc., Blackstone (Shanghai) Equity Invt Mgmt Co. Ltd. is a Chinese company that provides investment management services. The private company is based in Shime Yi, China. | Finance |
New Frontier Health Corp.
New Frontier Health Corp. Hospital/Nursing ManagementHealth Services New Frontier Health Corp. is a private healthcare provider offering healthcare services in China. The firm's United Family Healthcare platform consists of a network of seven private hospitals and affiliated ambulatory clinics. It's 700 licensed inpatient beds, together with its clinic network, spans eight metropolitan areas, including all four 1st tier cities in China. The company was founded by Kam Chung Leung and Carl Wu on March 28, 2018 and is headquartered in Hong Kong. | Health Services |
Genetron Holdings Ltd.
Genetron Holdings Ltd. Medical/Nursing ServicesHealth Services Genetron Holdings, Ltd. engages in precision oncology. It provides cancer molecular profiling by using technologies in molecular biology and data science to transform cancer treatment. It products and services include diagnosis and monitoring through both LDT and IVD products. Its LDT portfolio consists of both specifically designed focused and comprehensive gene panel testing services. It also develops liver cancer early screening products. The company was founded by Si Zhen Wang, Hai Yan, and Wei Wu He in 2015 and is headquartered in Beijing, China. | Health Services |
VISEN Pharmaceuticals (Shanghai) Co., Ltd.
VISEN Pharmaceuticals (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology VISEN Pharmaceuticals (Shanghai) Co., Ltd. is a Chinese pharmaceutical company that focuses on the development of products and technology for endocrine diseases. The company is based in Shanghai, China, and the CEO of the company is An Bang Lu. The company has developed a product called Long Pei, which is the first American FDA-approved growth hormone that can be released within a week to deliver growth hormone. VISEN Pharmaceuticals has also entered into a strategic cooperation agreement with Peking University Clinical Research Institute to carry out clinical research on thyroid dysfunction. | Health Technology |
Esco Lifesciences Group Ltd.
Esco Lifesciences Group Ltd. Miscellaneous Commercial ServicesCommercial Services Esco Lifesciences Group Ltd. is a multinational life sciences company, engages in the development, manufacture, and sale of life sciences, pharmaceutical and bioprocessing tools as well as the offering of related after-sales and support services. It operates through the following segments: Esco Scientific, Esco Medical, Esco Healthcare, and Esco Services. The Esco Scientific segment provides mission critical life sciences laboratory equipment such as biological safety cabinets, laminar flow clean benches, CO2 and CO2/O2 incubators, fume hoods, centrifuges and others used in research, clinical and industrial settings for preparation, cultivation, handling and analytical purposes. The Esco Medical segment manufactures and sells medical devices such as incubators, workstations, and consumables for IVF treatment. The Esco Healthcare segment provides pharmaceutical equipment and bioprocessing tools, primarily containment and isolation systems for the production of medicines, vaccines, and cell and gene therapies. The Esco Services segment offers after-sales and support services to customers of Esco Scientific, Esco Medical, and Esco Healthcare. The company was founded on February 1, 2021 and is headquartered in Singapore. | Commercial Services |
VISEN Pharmaceuticals
VISEN Pharmaceuticals BiotechnologyHealth Technology VISEN Pharmaceuticals operates as a biopharmaceutical company. It focuses on developing therapies and patient-centric care on endocrine diseases. The firm operates a segment which is developing and commercializing paradigm-shifting endocrine therapies in Greater China. The company was founded on November 1, 2018 and is headquartered in Shanghai, China. | Health Technology |